Recall of AFX Endovascular AAA System of the AFX device with Strata Graft material and AFX2 device in 28 mm Main Body and / or 20 mm Iliac Limbs

Greek data is current through July 2018. All of the data comes from the National Organization for Medicines, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Greece.